Paper Details

  1. Home
  2. Paper Details

[Overall clinical evaluation of cefpodoxime proxetil against infections in pediatric fields].

Author: AbeT, ArimasuO, FujiiR, IsekiK, MeguroH, MuronoK, SakataH, ShiraishiH, TakahashiY, YoshiokaH

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
English AbstractA summary of a research paper/publication written in English for a wider audience.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.

Overview

Cefpodoxime proxetil (CPDX-PR) was effective in treating various pediatric infections, with a 94.6% clinical efficacy rate and a low incidence of side effects.
Paper Details　
Original Abstract of the Article :
Dry syrup and tablet of newly developed cefpodoxime proxetil (CS-807, CPDX-PR) was investigated in the departments of pediatrics of 17 institutes and their related hospitals. 1. Pharmacokinetics of CPDX-PR in pediatrics were investigated. Peak blood levels of CPDX at dose levels of 3 mg/kg and 6 mg/...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/2681863

データ提供：米国国立医学図書館（NLM）

Cefpodoxime Proxetil: A New Oasis in Pediatric Infections

This study explores the efficacy and safety of cefpodoxime proxetil, a new antibiotic, in treating infections in children. Think of this antibiotic as a newly discovered oasis in the desert of pediatric illnesses, offering relief from various bacterial infections.

A New Hope for Pediatric Infections: Cefpodoxime Proxetil

This study tested cefpodoxime proxetil in a variety of pediatric infections, including tonsillitis, urinary tract infections, pneumonia, impetigo, scarlet fever, and pharyngitis/laryngitis. The results show that this antibiotic is effective in treating these infections, offering a promising solution for children battling bacterial infections.

A Safe and Effective Oasis for Pediatric Infections

The researchers found that cefpodoxime proxetil is generally well-tolerated in children. This is like finding a safe and refreshing oasis in the harsh desert of potential side effects. The study provides evidence for the safe and effective use of cefpodoxime proxetil in treating common pediatric infections.

Dr.Camel's Conclusion

This study shines a light on the potential benefits of cefpodoxime proxetil for treating pediatric infections. It's like finding a new oasis in the desert of childhood illnesses, offering relief and hope for young patients. The study highlights the importance of continued research to develop safe and effective treatments for children suffering from infections.

Date :
  1. Date Completed 1989-12-04
  2. Date Revised 2023-12-13
Further Info :

Pubmed ID

2681863

DOI: Digital Object Identifier

2681863

Related Literature

Article Analysis
・Side Effects of cefpodoxime
SNS
PICO Info
in preparation
Languages

Japanese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.